Clinical Trials Browser

Phase 3 × lanreotide × Endocrine × Clear all

NCT05477576 2026-01-20

ACTION-1

Phase 3 Recruiting

EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Carcinoid Tumor, Adenoma, Islet Cell, Neuroendocrine Tumors

NCT06878664 2025-09-02

RIALTO

Phase 3 Recruiting

Neuroendocrine Tumors

NCT00774930 2022-10-14

ELECT

Phase 3 Completed

115 enrolled 17 charts

Carcinoid Tumor, Diarrhea, Flushing, Neuroendocrine Tumors, Serotonin Syndrome

NCT00842348 2022-10-12

NET729

Phase 3 Completed

89 enrolled 9 charts

Neuroendocrine Tumors

NCT02683941 2022-07-06

SPINET

Phase 3 Terminated

77 enrolled 20 charts

Neuroendocrine Tumors in Lung

NCT04065165 2020-02-05

TELEFIRST

Phase 3 Withdrawn

Carcinoid Heart Disease, Serotonin Syndrome

NCT03439709 2018-03-01

MERGE

Phase 3 Unknown

Acromegaly, Pituitary Neoplasms, Growth Hormone-Secreting Pituitary Adenoma